Invesco Nasdaq Biotechnology ETF Rating $22.52 +0.05 (+0.22%) Closing price 03/7/2025 03:59 PM EasternExtended Trading$22.51 -0.01 (-0.04%) As of 03/7/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.74Holdings in IBBQ have an aggregate rating of Moderate Buy based on 2,350 analyst ratings issued in the past year covering 259 companies (99.8% of the portfolio).IBBQ Aggregate Price Target$22.52High Prediction$22.52Average Prediction$22.52Low Prediction$22.52Holdings in IBBQ have an aggregate price target of $22.52 and a range of $22.52 to $22.52 covering 259 companies (99.8% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy122 Buy rating(s)Moderate Buy97 Moderate Buy rating(s)Hold33 Hold rating(s)Reduce5 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.15%GILDGilead Sciences$117.41+1.2%4.684 of 5 stars2.72$104.24 -11.2%29Positive News9.07%AMGNAmgen$324.86+2.2%4.1132 of 5 stars2.46$314.95 -3.0%24Dividend AnnouncementAnalyst RevisionPositive News8.50%VRTXVertex Pharmaceuticals$488.29+0.5%3.8763 of 5 stars2.65$506.70 3.8%26Positive News7.36%REGNRegeneron Pharmaceuticals$707.51+1.3%4.7207 of 5 stars2.76$973.13 37.5%254.27%AZNAstraZeneca$77.50+0.0%2.9131 of 5 stars3.10$89.75 15.8%10Positive News2.97%ALNYAlnylam Pharmaceuticals$244.52-1.5%4.253 of 5 stars2.72$304.26 24.4%25Analyst Revision1.97%BIIBBiogen$150.38+2.0%4.7751 of 5 stars2.43$213.33 41.9%30Positive News1.95%ARGXargenx$594.21-3.1%3.2716 of 5 stars2.86$662.83 11.5%221.58%SNYSanofi$59.25-0.3%2.9732 of 5 stars3.25$60.00 1.3%4Analyst Revision1.44%RPRXRoyalty Pharma$33.01-0.8%4.9545 of 5 stars3.00$41.60 26.0%6Positive News1.40%UTHRUnited Therapeutics$315.91+2.7%4.6445 of 5 stars2.67$388.25 22.9%12Positive News1.37%ILMNIllumina$86.62+2.3%4.7244 of 5 stars2.48$149.25 72.3%211.37%INSMInsmed$74.89-0.2%3.9098 of 5 stars3.00$93.33 24.6%161.36%INCYIncyte$70.79+1.0%4.394 of 5 stars2.32$75.25 6.3%191.32%ITCIIntra-Cellular Therapies$131.240.0%3.6739 of 5 stars2.47$106.08 -19.2%15Gap Up1.32%SMMTSummit Therapeutics$17.78-6.4%1.8492 of 5 stars2.88$34.63 94.7%81.28%BMRNBioMarin Pharmaceutical$72.23+1.4%4.9707 of 5 stars2.71$94.00 30.1%24Analyst UpgradePositive News1.19%ONCBeigene$247.07-3.9%2.2885 of 5 stars3.00$316.50 28.1%2Insider TradeGap Down1.16%MRNAModerna$35.61+3.8%4.4816 of 5 stars2.04$60.63 70.3%231.15%NBIXNeurocrine Biosciences$113.04+0.3%4.9282 of 5 stars2.83$165.24 46.2%23Analyst Forecast1.10%VTRSViatris$9.65+1.5%1.4711 of 5 stars1.75$10.50 8.8%4Analyst Forecast1.04%EXELExelixis$38.58+1.0%4.2633 of 5 stars2.50$37.24 -3.5%201.03%BNTXBioNTech$108.78-1.8%1.8025 of 5 stars2.88$142.72 31.2%170.98%MEDPMedpace$332.81+2.2%4.1956 of 5 stars2.45$381.44 14.6%110.95%SRPTSarepta Therapeutics$103.03-2.4%4.8206 of 5 stars2.83$170.41 65.4%23Analyst Forecast0.90%PCVXVaxcyte$71.18-4.9%2.0596 of 5 stars3.00$147.50 107.2%9Positive News0.89%ASNDAscendis Pharma A/S$145.74-3.8%3.0763 of 5 stars2.93$202.36 38.8%140.84%JAZZJazz Pharmaceuticals$138.81+1.7%4.8629 of 5 stars2.93$189.40 36.4%15Analyst UpgradeInsider Trade0.82%TEMTempus AI$49.10+0.5%1.9065 of 5 stars2.50$61.18 24.6%12Insider TradeGap Up0.73%ROIVRoivant Sciences$10.64+0.4%2.4262 of 5 stars3.00$18.08 70.0%70.71%HALOHalozyme Therapeutics$60.98+1.4%4.1891 of 5 stars2.60$62.78 2.9%100.71%MDGLMadrigal Pharmaceuticals$331.41+0.8%4.095 of 5 stars2.85$375.75 13.4%13Insider Trade0.64%RVMDRevolution Medicines$39.210.0%4.6254 of 5 stars3.08$66.31 69.1%130.63%BBIOBridgeBio Pharma$31.57-2.0%4.5419 of 5 stars2.92$51.55 63.3%12Insider Trade0.59%AXSMAxsome Therapeutics$122.17-1.8%4.6202 of 5 stars3.00$167.36 37.0%150.56%BPMCBlueprint Medicines$87.12-1.6%2.8414 of 5 stars2.67$125.21 43.7%21Analyst ForecastAnalyst Revision0.54%CYTKCytokinetics$43.43+0.4%3.9112 of 5 stars2.94$82.00 88.8%18Insider TradeAnalyst Revision0.53%ALKSAlkermes$34.35-0.9%3.9957 of 5 stars2.75$38.33 11.6%12Analyst RevisionPositive News0.50%GHGuardant Health$39.32-2.1%4.33 of 5 stars3.00$48.40 23.1%200.48%IONSIonis Pharmaceuticals$33.81-1.7%4.4141 of 5 stars2.70$60.00 77.5%200.48%KRYSKrystal Biotech$179.93+0.6%4.4988 of 5 stars3.00$220.00 22.3%80.48%NUVLNuvalent$71.07-2.6%2.0714 of 5 stars2.85$113.10 59.1%130.48%VRNAVerona Pharma$64.65-1.6%1.9035 of 5 stars3.14$66.83 3.4%70.38%PTCTPTC Therapeutics$52.59-0.4%3.7657 of 5 stars2.47$61.77 17.5%15Analyst Forecast0.38%RAREUltragenyx Pharmaceutical$38.62-3.5%4.4466 of 5 stars2.93$93.50 142.1%140.38%SWTXSpringWorks Therapeutics$49.55-3.4%2.6195 of 5 stars3.00$73.20 47.7%5High Trading Volume0.36%CRSPCRISPR Therapeutics$45.53+5.1%3.27 of 5 stars2.48$73.11 60.6%210.35%ADMAADMA Biologics$17.02+0.7%2.9821 of 5 stars3.25$22.50 32.2%40.34%RNAAvidity Biosciences$30.29-0.2%2.1359 of 5 stars3.00$65.64 116.7%11Analyst ForecastGap Down0.33%SRRKScholar Rock$36.00-0.4%3.7075 of 5 stars3.14$40.43 12.3%70.32%AKROAkero Therapeutics$42.12-3.5%4.0155 of 5 stars3.00$76.29 81.1%9Insider Trade0.32%ACLXArcellx$70.74+3.1%2.2502 of 5 stars3.13$108.46 53.3%15Gap Up0.32%RYTMRhythm Pharmaceuticals$50.79-1.6%4.1673 of 5 stars2.92$69.31 36.5%13Analyst Forecast0.31%APLSApellis Pharmaceuticals$25.04-1.1%4.4128 of 5 stars2.63$45.53 81.8%190.31%ACADACADIA Pharmaceuticals$17.56-0.3%4.5404 of 5 stars2.53$24.00 36.7%17Analyst Forecast0.31%MRUSMerus$46.07-0.1%3.1726 of 5 stars3.13$85.77 86.2%160.30%CRNXCrinetics Pharmaceuticals$33.28-2.4%4.2516 of 5 stars2.92$72.64 118.3%13Positive News0.30%ALVOAlvotech$11.15+0.2%2.1485 of 5 stars3.00$18.00 61.4%20.29%IMVTImmunovant$20.02+2.6%2.3188 of 5 stars2.92$43.55 117.5%130.29%LEGNLegend Biotech$35.26+3.2%1.7504 of 5 stars3.00$79.50 125.5%12Upcoming EarningsPositive News0.28%RXRXRecursion Pharmaceuticals$6.59+5.6%2.518 of 5 stars2.40$8.25 25.2%50.28%XENEXenon Pharmaceuticals$36.50-2.1%1.9764 of 5 stars3.00$57.38 57.2%90.27%FOLDAmicus Therapeutics$8.86-1.8%4.4253 of 5 stars2.78$16.75 89.1%90.26%DNLIDenali Therapeutics$16.69+2.6%4.2391 of 5 stars2.94$37.27 123.3%18Analyst ForecastAnalyst Revision0.25%AMRXAmneal Pharmaceuticals$8.90+1.6%2.4143 of 5 stars3.00$10.80 21.3%50.25%VCYTVeracyte$32.02-1.5%4.3667 of 5 stars2.63$43.00 34.3%80.24%EWTXEdgewise Therapeutics$28.01-0.4%1.6733 of 5 stars2.88$45.38 62.0%8Earnings ReportAnalyst ForecastOptions VolumePositive NewsHigh Trading Volume0.24%VCELVericel$49.56+1.6%2.7017 of 5 stars3.00$62.29 25.7%7Analyst Upgrade0.23%ARWRArrowhead Pharmaceuticals$16.97-4.0%3.8125 of 5 stars2.60$41.44 144.2%100.22%BEAMBeam Therapeutics$28.48+4.5%3.6182 of 5 stars2.92$51.00 79.1%130.22%MIRMMirum Pharmaceuticals$43.46+0.1%4.1508 of 5 stars3.09$58.20 33.9%11Positive News0.22%TWSTTwist Bioscience$39.43+0.6%3.9377 of 5 stars2.70$54.40 38.0%100.21%LGNDLigand Pharmaceuticals$114.83-1.0%4.7595 of 5 stars3.00$147.00 28.0%6Gap Up0.21%PTGXProtagonist Therapeutics$38.35-1.8%3.4954 of 5 stars3.00$55.89 45.7%9High Trading Volume0.20%NVCRNovoCure$20.18+4.8%3.5627 of 5 stars2.67$32.67 61.9%60.19%AGIOAgios Pharmaceuticals$32.38-4.7%4.3901 of 5 stars2.56$56.57 74.7%9Analyst Revision0.19%IBRXImmunityBio$3.00+0.3%2.0422 of 5 stars3.00$12.19 306.3%5Earnings ReportAnalyst Revision0.19%KYMRKymera Therapeutics$32.89+1.1%1.6928 of 5 stars2.86$56.69 72.4%140.19%NAMSNewAmsterdam Pharma$23.80+1.3%2.5501 of 5 stars3.00$43.80 84.0%6High Trading Volume0.18%HRMYHarmony Biosciences$33.67-0.1%4.5428 of 5 stars3.00$53.11 57.7%90.18%VERAVera Therapeutics$28.82-1.6%2.1995 of 5 stars3.20$64.67 124.4%10Analyst Revision0.17%DVAXDynavax Technologies$14.40+0.4%3.9256 of 5 stars2.33$21.50 49.3%30.17%BCRXBioCryst Pharmaceuticals$7.69-2.2%4.4693 of 5 stars2.86$15.57 102.5%70.17%IDYAIDEAYA Biosciences$18.46-3.2%4.1136 of 5 stars2.93$53.58 190.3%15Gap Up0.17%SUPNSupernus Pharmaceuticals$32.07+0.8%2.4477 of 5 stars2.33$36.00 12.3%3Analyst Downgrade0.17%TVTXTravere Therapeutics$18.09-4.5%2.2394 of 5 stars2.93$30.62 69.2%140.17%ZLABZai Lab$36.42+2.9%1.7373 of 5 stars3.00$45.03 23.7%4Analyst Forecast0.16%CGONCG Oncology$26.72-1.0%1.1457 of 5 stars3.10$63.88 139.1%10Analyst Forecast0.16%IOVAIovance Biotherapeutics$3.754.4659 of 5 stars2.88$20.25 440.0%80.16%IRONDisc Medicine$55.67+0.3%2.9503 of 5 stars3.09$89.10 60.1%11Analyst ForecastAnalyst Revision0.16%JANXJanux Therapeutics$30.64-0.4%3.5039 of 5 stars3.08$88.00 187.2%13Upcoming EarningsInsider Trade0.16%TARSTarsus Pharmaceuticals$46.47+6.7%2.8219 of 5 stars3.00$63.67 37.0%70.16%WVEWave Life Sciences$9.40-7.7%4.2003 of 5 stars3.00$22.60 140.4%10Earnings ReportAnalyst UpgradeInsider TradeAnalyst Revision0.15%AMPHAmphastar Pharmaceuticals$28.81+1.7%4.088 of 5 stars2.00$45.50 57.9%30.15%ARQTArcutis Biotherapeutics$14.72+1.5%2.5938 of 5 stars2.83$18.00 22.3%60.14%MNKDMannKind$4.98+1.2%2.5403 of 5 stars3.13$9.21 85.0%8Analyst Upgrade0.13%DYNDyne Therapeutics$12.40+1.3%3.3663 of 5 stars3.07$48.75 293.1%14Earnings ReportAnalyst Forecast0.13%GPCRStructure Therapeutics$22.62-3.9%2.7721 of 5 stars3.00$81.29 259.4%80.13%CNTACentessa Pharmaceuticals$16.23-3.2%2.3864 of 5 stars3.00$26.00 60.2%7Analyst Forecast0.13%APGEApogee Therapeutics$36.14+2.0%2.7452 of 5 stars3.00$91.60 153.5%5Earnings ReportInsider TradeHigh Trading Volume This page (NASDAQ:IBBQ) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI Shock Coming on March 18? Prepare NowIf you’re worried about all the recent volatility in the market… Or if you have any money in AI stocks… ...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.